May 2011 USANs
The May 2011 USANs have been published.
| USAN | Research Code | Structure | Drug Type | Drug Class | Target |
| alisertib, alisertib sodium | MLN-8237 |  | synthetic small molecule | therapeutic | AURa, AURb |
| asunaprevir | BMS-650032 |  | synthetic small molecule | therapeutic | HCV NS3 |
| cariprazine, cariprazine hydrochloride | RGH-188 |  | synthetic small molecule | therapeutic | D2R D3R |
| ceftolozane, ceftolozane sulfate | CXA-101 |  | natural product-derived small molecule | therapeutic | various PBPs |
| crenezumab | MABT5102A | monoclonal antibody | therapeutic | Abeta | |
| dalantercept | ACE-041 |  | protein | therapeutic | TGFbeta family |
| delcasertib, delcasertib acetate | KAI-9803, BMS-875944 |  | peptide | therapeutic | PKCdelta |
| epelsiban, epelsiban besylate | GSK-557296B |  | synthetic small molecule | therapeutic | Oxytocin receptor |
| erismodegib | LDE-225 |  | synthetic small molecule | therapeutic | Smo |
| evacetrapib | LY-2484595 |  | synthetic small molecule | therapeutic | CETP |
| ficlatuzumab | SCH-900105, AV-299 | monoclonal antibody | therapeutic | HGF | |
| galeterone | TOK-001, VN-124 |  | natural product-derived small molecule | therapeutic | AR |
| icopasent ethyl | AMR-101 |  | natural product-derived small molecule | supplement | - |
| macitentan | ACT-064992 |  | synthetic small molecule | therapeutic | ETRa ETRb |
| oclacitinib, oclacitinib maleate | PF-03394197 |  | synthetic small molecule | therapeutic | |
| sarilumab | REG-N88, SAR-153191 | monoclonal antibody | therapeutic | IL6R | |
| sitaxentan sodium | TBC-11251z, TBC-11251Na |  | synthetic small molecule | therapeutic | ETRa ETRb |
| tofacitinib citrate | CP-690550-10 |  | synthetic small molecule | therapeutic | JAK2, JAK3 |
| trametinib, trametinib dimethyl sulfoxide | GSK-1120212 |  | synthetic small molecule | therapeutic | MEK |
| volasertib, volasertib trihydrochloride | BI-6727 |  | synthetic small molecule | therapeutic | PLK1 |
| vonicog alfa | BAX-111 |  | protein | supplement |
A fair few kinase inhibitors, but does anyone know anything about Oclacitinib - Google shows only some dog cancer trials at the moment?